SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Lupin Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
500257 INE326A01037 531.5387173 LUPIN 0.63 86,468.20 16.39 115.47 2
Quarters :
ParticularsJun 2025(Rs.Cr)Mar 2025(Rs.Cr)Dec 2024(Rs.Cr)
Gross Sales5605.414382.694060.16
Other Operating Income103.18102.98147.84
Other Income 54.1448.7955.30
Total Income5762.734534.464263.30
Total Expenditure 2978.952739.542874.17
PBIDT2783.781794.921389.13
Interest 18.9033.8519.55
PBDT2764.881761.071369.58
Depreciation176.73207.98152.52
Tax451.54270.25225.73
Fringe Benefit Tax0.000.000.00
Deferred Tax8.54-8.516.66
Reported Profit After Tax2128.071291.35984.67
Extra-ordinary Items 0.000.00-62.48
Adjusted Profit After Extra-ordinary item2128.071291.351047.15
    
EPS (Unit Curr.)46.6028.3021.58
EPS (Adj) (Unit Curr.)46.6028.3021.58
Calculated EPS (Unit Curr.)46.5928.2821.58
Calculated EPS (Adj) (Unit Curr.)46.5928.2821.58
Calculated EPS (Ann.) (Unit Curr.)186.37113.1386.33
Calculated EPS (Adj) (Ann.) (Unit Curr.)186.37113.1386.33
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity91.3591.3291.25
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)49.6640.9534.21
PBDTM(%)49.3340.1833.73
PATM(%)37.9629.4624.25